Meruert Sarsenova

No ORCID on file · 9 papers in corpus · active 2024-2025

Study types

  • preprint 6
  • other 3

Condition tags

  • endometriosis 9
  • chronic_pelvic_pain 6
  • infertility 5
preprint 2025
·doi:10.69622/28227977

Endometriosis is a prevalent benign gynecological disease in women of reproductive age. It is estimated to affect globally around 190 million people, or approximately every tenth woman. Symptomatically endometriosis usually manifests with c…

preprint 2025
·doi:10.69622/28227977.v3

Endometriosis is a prevalent benign gynecological disease in women of reproductive age. It is estimated to affect globally around 190 million people, or approximately every tenth woman. Symptomatically endometriosis usually manifests with c…

preprint 2025
·doi:10.69622/28227977.v2

Endometriosis is a prevalent benign gynecological disease in women of reproductive age. It is estimated to affect globally around 190 million people, or approximately every tenth woman. Symptomatically endometriosis usually manifests with c…

preprint 2025
·doi:10.69622/28227977.v1

Endometriosis is a prevalent benign gynecological disease in women of reproductive age. It is estimated to affect globally around 190 million people, or approximately every tenth woman. Symptomatically endometriosis usually manifests with c…

preprint 2025
·doi:10.69622/28227977.v4

Endometriosis is a prevalent benign gynecological disease in women of reproductive age. It is estimated to affect globally around 190 million people, or approximately every tenth woman. Symptomatically endometriosis usually manifests with c…

other 2024
Genes ·doi:10.3390/genes15081086

Endometriosis is a chronic hormone-dependent disease characterized by the spread of endometrial cells outside the uterus, which form endometriotic lesions and disrupt the functions of the affected organs. The etiopathogenesis of endometrios…

other 2024
Communications biology ·doi:10.1038/s42003-024-06713-5

Current therapeutics of endometriosis focus on hormonal disruption of endometriotic lesions (ectopic endometrium, EcE). Recent findings show higher glycolysis utilization in EcE, suggesting non-hormonal strategy for disease treatment that a…

preprint 2024
·doi:10.1101/2024.02.27.580606

Abstract Current therapeutics of endometriosis are limited to hormonal action on endometriotic lesions to disrupt their growth. Based on the recent findings of the high utilization of glycolysis over oxidative metabolism (Warburg-like effec…

other 2024
Frontiers in endocrinology ·doi:10.3389/fendo.2024.1465393

BACKGROUND: Endometriosis is characterized by the ectopic growth of endometrial-like cells, causing chronic pelvic pain, adhesions and impaired fertility in women of reproductive age. Usually, these lesions grow in the peritoneal cavity in …